We found that LINC00460 is overexpressed in five different epithelial cancers, namely: Breast cancer (BRCA) (Figure 1B); Colon adenocarcinoma (COAD); Head and Neck Squamous cell carcinoma (HNSC), Pancreatic adenocarcinoma (PAAD) and Rectum adenocarcinoma (READ) (Log2FC>1; p<0.05) (Figure 1A). Here, LINC00460 is linked to colon adenocarcinoma.